Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saffron for depression and serum lipids
IRCT2013110915334N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of saffron in major depressive disorder (MDD) and dyslipidemia, sponsored by Shiraz University of Medical Sciences. Started Dec 2012; status: completed.
02
Drugs
saffron
03
Conditions
major depressive disorder (MDD)dyslipidemia
Beyond the preview
Go deeper on IRCT2013110915334N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013110915334N1.